관련근거
·식품의약품안전처 허가사항
·Memory Loss, Alzheimer's Disease and Dementia, 3e, 2022> Chapter 19. Cholinesterase Inhibitors
·CURRENT Diagnosis & Treatment: Neurology, 3e, 2019> Chapter 9: Dementia & Memory Loss
·Harrison's Principles of Internal Medicine, 21e, 2022> Chapter 431: Alzheimer’s Disease
·Bradley and Daroff's Neurology in Clinical Practice, 8e, 2022> Chapter 95. Alzheimer Disease and Other Dementias
·O'Brien JT, et al. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol. 2017 Feb;31(2):147-168.
·Rabins PV, et al. Guideline Watch (October 2014): Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias. Focus (Am Psychiatr Publ). 2017 Jan;15(1):110-128.
·Sadowsky CH, et al. Guidelines for the management of cognitive and behavioral problems in dementia. J Am Board Fam Med. 2012 May-Jun;25(3):350-66.
·Winslow BT, et al. Treatment of Alzheimer disease. Am Fam Physician. 2011 Jun 15;83(12):1403-12. Erratum in: Am Fam Physician. 2014 Aug 15;90(4):209.
·Hort J, et al. EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol. 2010 Oct;17(10):1236-48.
·Nagaendran K, et al. Ministry of health clinical practice guidelines: dementia. Singapore Med J. 2013 May;54(5):293-8.
·Homma A, et al. Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group. Dement Geriatr Cogn Disord. 2000 Nov-Dec;11(6):299-313.
·Homma A, et al. Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial. Dement Geriatr Cogn Disord. 2008;25(5):399-407.
·Rogers SL, et al. The Efficacy and Safety of Donepezil in Patients with Alzheimer‘s Disease: Results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. Dementia. 1996 Nov-Dec;7(6):293-303.
·Farlow MR, et al. Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study. Clin Ther. 2010 Jul;32(7):1234-51.
·대한비만학회. 비만 진료지침 2022. 8판.
·World Health Organization. Regional Office for the Western Pacific. (2000). The Asia-Pacific perspective : redefining obesity and its treatment. Sydney : Health Communications Australia.